486 related articles for article (PubMed ID: 35326670)
1. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
De P; Aske J; Sulaiman R; Dey N
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326670
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
5. A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Gaster K; Espaillat LR; Starks D; Dey N
Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238998
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
7. Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets.
Yan L; Zheng J; Wang Q; Hao H
Biochem Biophys Res Commun; 2023 Nov; 681():127-135. PubMed ID: 37774570
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
9. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures.
Feng B; Wu J; Shen B; Jiang F; Feng J
Cancer Cell Int; 2022 Apr; 22(1):166. PubMed ID: 35488263
[TBL] [Abstract][Full Text] [Related]
11. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment.
Ganguly D; Chandra R; Karalis J; Teke M; Aguilera T; Maddipati R; Wachsmann MB; Ghersi D; Siravegna G; Zeh HJ; Brekken R; Ting DT; Ligorio M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32957515
[TBL] [Abstract][Full Text] [Related]
13. Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer.
Mishra D; Banerjee D
Cells; 2023 Feb; 12(4):. PubMed ID: 36831295
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
15. Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights.
Chiu KJ; Chiou HC; Huang CH; Lu PC; Kuo HR; Wang JW; Lin MH
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327514
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy.
De P; Aske J; Dey N
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680395
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
Katsube R; Noma K; Ohara T; Nishiwaki N; Kobayashi T; Komoto S; Sato H; Kashima H; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Sci Rep; 2021 Jan; 11(1):1693. PubMed ID: 33462372
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts in neoadjuvant setting for solid cancers.
Gu Y; Chen Q; Yin H; Zeng M; Gao S; Wang X
Crit Rev Oncol Hematol; 2024 Jan; 193():104226. PubMed ID: 38056580
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
